This book introduces the concept of knowledge networks and markets (KNMs) in the life sciences, the emerging organisations and mechanisms to share and trade an increasing variety of knowledge assets.
This event was the first time the OECD has taken a systematic look at what marine biotechnology could contribute to the grand challenges of food and fuel security, population health, green growth and sustainable industries.
English, , 429kb
This guide comprises eight key points for planning public engagement activities. It contains a set of questions to help policy makers develop a plan from start to finish, as well as practical case studies from countries that have used the guide in their communication activities.
The Forum will explore topics such as regulatory considerations, skills and research support, intellectual property and community engagement. In addition, discussions will also focus on links between a ‘bioeconomy’ and synthetic biology.
Carbon dioxide (CO2) has the second-largest direct contribution to the greenhouse effect of all gases. Since the beginning of the Industrial Revolution, the burning of fossil fuels has contributed to the increase in carbon dioxide in the atmosphere.
This report describes the scientific, industrial, regulatory, and health care management system context in which biomarkers are being developed. It identifies some of the barriers which may impede biomarker research, discovery, development, commercialisation and, ultimately, uptake in clinics.
This book examines international drivers, enabling technologies fast-tracking industrial biotechnology, industry trends, some products appearing on the market, industry structure and finance, and policy measures and trends. It examines separately biofuels, biobased chemicals and bioplastics.
English, , 768kb
This report discusses ways in which both the public and private sectors are seeking to evolve from an “own and protect” model of intellectual property into an era of “own and share”, where value accrues not just to the initial owner of IP, but also to larger society as a whole.
Nowhere is innovation more relevant than in the context than human health. Thus, the recent economic worries have done much to bring the issues set out in this document even further up the political agenda.
This book examines the potential economic impacts of nanotechnology, how companies are using nanotechnology for innovation, and what the key challenges in its commercialisation might be.